MStranslate

14/11/2025

As many of you are aware, our co-founder - Brett Drummond - had the honour of once again hosting the Patient Community Day event at ECTRIMS 2025. In a recent blog article, he reflected on this experience and the importance of including people living with multiple sclerosis in the biggest MS research conference of the year.

A blog post by MS Translate, a Patient Community Day Supporting Partner, reflecting on the value of partnership between researchers and participants, showing that breakthroughs happen fastest when people living with these conditions are engaged as true collaborators, not just subjects.

10/11/2025

BREAKING NEWS: Roche have announced that their BTK inhibitor, fenebrutinib, has achieved successful trial results in both relapsing-remitting and primary progressive multiple sclerosis. While we have to wait until the full data is presented at upcoming conferences to know the entire story, this is positive news for the treatment of MS.

Read more: https://www.roche.com/investors/updates/inv-update-2025-11-10

08/11/2025

New research from Germany has shed more light on the link between the gut and multiple sclerosis. Scientists studied identical twins where only one sibling had MS, allowing them to pinpoint differences in their gut microbiomes. Not only did they find consistent changes in certain bacterial populations, but some of the bacteria from the twin with MS were able to trigger MS-like disease in an animal model. These findings strengthen the evidence that the gut microbiome may play an important role in the development and progression of MS and could one day guide new ways to prevent or treat the condition.

07/11/2025

Since her multiple sclerosis diagnosis, Justine has made self-care a priority, including discovering a love for painting. Taking time for yourself isn’t a luxury, it’s essential. What are you doing this weekend to look after your mind and body?

Geelong’s Justine Martin defied an MS diagnosis and multiple cancers to build a business empire and inspire others with resilience.

05/11/2025

This recent research from UCLA may indicate why women are more likely to develop multiple sclerosis than men. The findings also suggest that these differences may extend to how men and women respond to metformin, which is currently being investigated as a potential myelin repair therapy in MS.

Breadcrumb Home Medical Services Neurology Neurology Why women's brains face higher risk: scientists pinpoint X-chromosome gene behind MS and Alzheimer's Mouse study reveals how females' double X chromosomes drives brain inflammation and identifies diabetes drug as potential treatment October 14, 20...

04/11/2025

A study from the University of Nottingham has used new wearable technology to monitor how the brains of people living with multiple sclerosis are impacted when doing daily activities. It is hoped that this device may help improve our understanding of the impacts of MS, better predict outcomes and provide new opportunities to help manage the condition.

Learn more: https://www.nottingham.ac.uk/news/wearable-brain-imaging-technology-sheds-new-light-on-multiple-sclerosis

03/11/2025

A new telehealth-based lifestyle study at UOW: University of Wollongong, Australia is now recruiting. The HALT-MS program combines evidence-based diet, exercise and psychological support to help people living with MS better self-manage their symptoms and enhance wellbeing. This free six-month initiative connects people with health professionals and then includes a further six months to implement the tips and tools learned into daily life. You can learn more via the link below.

We use cookies to improve your experience on our site and to show you personalised advertising. To find out more, read our privacy policy and cookie policy

30/10/2025

Recently, Brett had the pleasure of being interviewed as part of the Multiple Sclerosis Trust podcast. The episode, now available via the link below, discusses key highlights from the 2025 ECTRIMS (European Committee for Treatment & Research in Multiple Sclerosis) conference and the importance of the Patient Community Day event.

In this episode we explore the biggest breakthroughs from ECTRIMS 2025, the world’s largest MS research conference. We look into new treatment insights, the ...

28/10/2025

If you live with MS or another chronic health condition, the holidays can sometimes be more exhausting than joyful. Our friends at Livology are running a FREE online webinar - All I Want for Christmas… Is My Sanity - hosted by psychologists Dr Sally Shaw and Seona Ilalio. They’ll share practical tips to help you manage energy, emotions and expectations this festive season. If you can't make it live, the recording will be available for 7 days after the event!

When: Monday 1st December, 2025 at 12 noon (AEDT)

Register here: https://resources.butyoulooksogood.com.au/livewebinar-signup

27/10/2025

There is a lot of interest around the potential benefits that CAR T-cell therapy may have for people living with multiple sclerosis. However, we are still at a stage where clinical trial information is needed to understand the effectiveness of this treatment approach. It is exciting that a trial has started at UCLH - University College London Hospitals NHS Foundation Trust and we will be providing updates as they become available.

Biology teacher Emily Henders says she understands the "scientific rationale" behind the treatment.

22/10/2025

“We think our work opens numerous opportunities for diagnosing, monitoring, and possibility treating MS. It could be a gamechanger for how we understand and manage this disease" - Dr Ahmed Abdelhak, UCSF

This major breakthrough shows that multiple sclerosis might begin affecting the brain long before diagnosis, paving the way for earlier and more effective care.

Image In the hu

21/10/2025

We have heard a lot about the gut microbiome in multiple sclerosis, but new research from the University of Iowa has found that differences in the oral microbiome also exist. While further studies are needed, these results may allow for new diagnostic or disease biomarkers to be identified and potential therapeutic avenues to be explored.